Artículos por temáticas

Lectins and neurodegeneration: A glycobiologist's perspective

Olejnik B, Ferens-Sieczkowska M.

Adv Clin Exp Med. 2025 May 23. doi: 10.17219/acem/204107. Online ahead of print.

Movement Disorders after Dengue Virus Infection: A Scoping Review

Rosca EC, Garg D, Perez-Lloret S, Mohamed Ibrahim N, Phokaewvarangkul O, Sringean J, Holla V, Yadav R, Desai S, Pal PK.

Mov Disord. 2025 Apr;40(4):583-604. doi: 10.1002/mds.30142. Epub 2025 Feb 8.

Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase

Mohamed FE, Alzyoud L, Ghattas MA, Tabouni M, Fienemann A, Trinh J, Baydoun I, Kizhakkedath P, Alblooshi H, Shaukat Q, Amouri R, Farrer MJ, Sassi SB, Al-Jasmi F.

Int J Mol Sci. 2025 Mar 27;26(7):3056. doi: 10.3390/ijms26073056.

Unlocking the future: Precision oligonucleotide therapy for targeted treatment of neurodegenerative disorders

Jain N, Roy AA, Madhusoodanan G, Preman NK, Pokale R, Pisay M, Mukharya A, Pandey A, Mutalik S.

Int J Biol Macromol. 2025 May;310(Pt 4):143515. doi: 10.1016/j.ijbiomac.2025.143515. Epub 2025 Apr 25.

Hypokinetic-rigid gait disorders with balance impairment - A walk through clinical and pathophysiological definitions

Jalles C, Guerreiro D, Pona-Ferreira F, Simões RM, Reimão S, Ferreira JJ.

Parkinsonism Relat Disord. 2025 Apr;133:107339. doi: 10.1016/j.parkreldis.2025.107339. Epub 2025 Feb 14.

Retrotransposon: an insight into neurological disorders from perspectives of neurodevelopment and aging

Zhang W, Huang C, Yao H, Yang S, Jiapaer Z, Song J, Wang X.

Transl Neurodegener. 2025 Mar 25;14(1):14. doi: 10.1186/s40035-025-00471-y.

Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies

Bernatoniene J, Plieskis M, Petrikonis K.

Pharmaceutics. 2025 Mar 9;17(3):352. doi: 10.3390/pharmaceutics17030352.

Astrocyte-synapse structural plasticity in neurodegenerative and neuropsychiatric diseases

Badia-Soteras A, Mak A, Blok TM, Boers-Escuder C, van den Oever MC, Min R, Smit AB, Verheijen MHG.

Biol Psychiatry. 2025 Apr 18:S0006-3223(25)01125-4. doi: 10.1016/j.biopsych.2025.04.011. Online ahead of print.

Investigating nanoparticle's utilization in stem cell therapy for neurological disorders

Aziz S, Anbreen S, Shahzad S, Ahmed MS, Sharma V, Yang J, Ali L.

Am J Stem Cells. 2025 Apr 15;14(1):1-13. doi: 10.62347/YGYM4976. eCollection 2025.

All-Cause and Cause-Specific Mortality in Parkinson's Disease: A Meta-Analysis

Lee YH, Song GG.

Neuroepidemiology. 2025 Apr 29:1-25. doi: 10.1159/000546136. Online ahead of print.

Charles Bonnet Syndrome associated with unilateral vision loss: A new diagnostic perspective

Forte G, Assaf N, Forte P, Jolly JK.

Ophthalmic Physiol Opt. 2025 May;45(3):681-688. doi: 10.1111/opo.13481. Epub 2025 Mar 18.

Overview of Metformin and Neurodegeneration: A Comprehensive Review

Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A.

Pharmaceuticals (Basel). 2025 Mar 28;18(4):486. doi: 10.3390/ph18040486.

The Role of Mitochondrial Pyruvate Carrier in Neurological Disorders

Liu Y, Yu X, Jiang W.

Mol Neurobiol. 2025 Mar;62(3):2846-2856. doi: 10.1007/s12035-024-04435-7. Epub 2024 Aug 23.

Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics

Ghannam IAY, Hassan RM, Abdel-Maksoud MS.

Bioorg Chem. 2025 Mar;156:108226. doi: 10.1016/j.bioorg.2025.108226. Epub 2025 Jan 30.

Muscle spindle receptors and their impact on Parkinson´s disease and Cerebral Palsy subjects

Bartels EM, Harrison A.

J Muscle Res Cell Motil. 2025 Mar;46(1):1-8. doi: 10.1007/s10974-024-09682-8. Epub 2024 Nov 14.